OrphanDrug
OrphanDrug
Pharma Knowledge Base

transient neonatal diabetes mellitus

MeSH: C563322ORPHA: 99886

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

neonatal diabetes mellitus characterized by hyperglycemia during the neonatal period that remits during infancy but recurs in later life in most patients

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with transient neonatal diabetes mellitus, sourced from HPO and Orphanet clinical annotations.

Intrauterine growth retardationSmall for gestational ageDehydrationHyperglycemiaHypoinsulinemiaMacroglossiaUmbilical herniaMaturity-onset diabetes of the youngTransient neonatal diabetes mellitusAbnormality of the kidneyAbnormality of the urinary systemHearing impairmentAbnormality of the nervous systemHypothyroidismSeizureHypotoniaFailure to thriveAbnormal heart morphologyNeurodevelopmental delayAbnormality of limbsDiabetic ketoacidosis

Classification & Codes

MeSH Code

C563322

Orphanet Code

ORPHA:99886
transient neonatal diabetes mellitus
MeSHC563322
OrphanetORPHA:99886
Treatments0 drug(s)
Symptoms on record21 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO